Literature DB >> 11721175

Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry.

M Srinivasan1, S D Jewell.   

Abstract

OBJECTIVE: Oral leukoplakia (OL) and oral submucous fibrosis (OSMF) are clinically distinct preneoplastic states that precede the development of oral squamous cell carcinoma. Recently, attempts are being made to identify specific molecular event(s) as prognostic markers to identify oral precancerous lesions with higher malignant potential. The goal of the present study was to evaluate the expression of EGFR and its ligand TGF-alpha in OL with dysplasia and OSMF as intermediate markers of malignancy by quantitative immunohistochemistry.
METHODS: Oral tissues were stained with monoclonal antibodies to TGF-alpha and EGFR. The results were analyzed with Photoquant image analysis software.
RESULTS: The expression of TGF-alpha and EGFR was upregulated in OL, OSMF and oral squamous cell carcinomas relative to normal oral mucosa. The area and intensity of staining of TGF-alpha in the proliferative layers (stratum germinativum) increased linearly in OL with mild, moderate and severe dysplasia as compared to control mucosa (p < 0.05). EGFR levels increased linearly in the stratum spinosum in OL with increasing degrees of dysplasia (p < 0.05). In general, the expression of both proteins in OSMF was similar to that in OL with moderate dysplasia.
CONCLUSIONS: EGFR and TGF-alpha represent early markers of malignancy in OL with dysplasia. Quantitative measurement of these proteins may provide intermediate endpoints in prospective chemopreventive trials. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11721175     DOI: 10.1159/000055335

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  16 in total

1.  MIEN1 promotes oral cancer progression and implicates poor overall survival.

Authors:  Smrithi Rajendiran; Marilyne Kpetemey; Sayantan Maji; Lee D Gibbs; Subhamoy Dasgupta; Rebecca Mantsch; Richard J Hare; Jamboor K Vishwanatha
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa.

Authors:  Kelsey J Rosbach; Michelle D Williams; Ann M Gillenwater; Rebecca R Richards-Kortum
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

Review 3.  Molecular changes in the multistage pathogenesis of head and neck cancer.

Authors:  Brian J Park; Simion I Chiosea; Jennifer R Grandis
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Association between oral leukoplakia and upper gastrointestinal cancers: a 28-year follow-up study in the Linxian General Population Trial.

Authors:  J-H Fan; J-B Wang; C-X Qu; Y-Q Zhang; P R Taylor; C C Abnet; S M Dawsey; Y-L Qiao
Journal:  Oral Oncol       Date:  2014-08-11       Impact factor: 5.337

5.  MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation.

Authors:  Satish K Madala; Stephanie Schmidt; Cynthia Davidson; Machiko Ikegami; Susan Wert; William D Hardie
Journal:  Am J Respir Cell Mol Biol       Date:  2011-10-20       Impact factor: 6.914

6.  Molecular Analysis as a Guide to Determining the Extent and Pathophysiology of Perilesional Tissues in Oral Epithelial Dysplasias.

Authors:  Meenakshi Singhal; Ankita Tandon; Saurabh Juneja; Devi Charan Shetty; Sanjeev Kumar; Anshi Jain
Journal:  J Maxillofac Oral Surg       Date:  2019-11-11

7.  Expression of epidermal growth factor receptor in the inverted papilloma and squamous cell carcinoma of nasal cavity.

Authors:  Jiung-Chih Chao; Sheen-Yie Fang
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-30       Impact factor: 2.503

8.  Immunohistochemical expression of EGFR in oral leukoplakia: association with clinicopathological features and cellular proliferation.

Authors:  Daniela-Cotta Ribeiro; Frederico-Omar Gleber-Netto; Sílvia-Ferreira Sousa; Vanessa-de-Fátima Bernardes; Mauro-Henrique-Nogueira Guimarães-Abreu; Maria-Cássia-Ferreira Aguiar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-09-01

Review 9.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

10.  Expression of epithelial growth factor receptor in oral epithelial dysplastic lesions.

Authors:  Manickam Rajakili Chockalingam Rajeswari; Thillai Rajasekaran Saraswathi
Journal:  J Oral Maxillofac Pathol       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.